Targeted magnetic liposomes loaded with doxorubicin
- PMID: 20072888
- DOI: 10.1007/978-1-60327-360-2_19
Targeted magnetic liposomes loaded with doxorubicin
Abstract
Targeted delivery systems for anticancer drugs are urgently needed to achieve maximum therapeutic efficacy by site-specific accumulation and thereby minimizing adverse effects resulting from systemic distribution of many potent anticancer drugs. We have prepared folate receptor targeted magnetic liposomes loaded with doxorubicin, which are designed for tumor targeting through a combination of magnetic and biological targeting. Furthermore, these liposomes are designed for hyperthermia-induced drug release to be mediated by an alternating magnetic field and to be traceable by magnetic resonance imaging (MRI). Here, detailed preparation and relevant characterization techniques of targeted magnetic liposomes encapsulating doxorubicin are described.
Similar articles
-
Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.J Control Release. 2010 Feb 25;142(1):108-21. doi: 10.1016/j.jconrel.2009.10.002. Epub 2009 Oct 9. J Control Release. 2010. PMID: 19819275
-
Targeted Magnetic Liposomes Loaded with Doxorubicin.Methods Mol Biol. 2017;1522:257-272. doi: 10.1007/978-1-4939-6591-5_21. Methods Mol Biol. 2017. PMID: 27837546
-
Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.Cancer Chemother Pharmacol. 2010 May;66(1):43-52. doi: 10.1007/s00280-009-1132-4. Epub 2009 Sep 25. Cancer Chemother Pharmacol. 2010. PMID: 19779718
-
Folate receptor-targeted drugs for cancer and inflammatory diseases.Adv Drug Deliv Rev. 2004 Apr 29;56(8):1055-8. doi: 10.1016/j.addr.2004.02.003. Adv Drug Deliv Rev. 2004. PMID: 15094205 Review. No abstract available.
-
Tumour-selective drug delivery via folate receptor-targeted liposomes.Expert Opin Drug Deliv. 2004 Nov;1(1):7-17. doi: 10.1517/17425247.1.1.7. Expert Opin Drug Deliv. 2004. PMID: 16296717 Review.
Cited by
-
Co-delivery of doxorubicin and SATB1 shRNA by thermosensitive magnetic cationic liposomes for gastric cancer therapy.PLoS One. 2014 Mar 27;9(3):e92924. doi: 10.1371/journal.pone.0092924. eCollection 2014. PLoS One. 2014. PMID: 24675979 Free PMC article.
-
Comprehensive Evaluation of Gene Expression in Negative and Positive Trigger-based Targeting Niosomes in HEK-293 Cell Line.Iran J Pharm Res. 2020 Winter;19(1):166-180. doi: 10.22037/ijpr.2019.112058.13507. Iran J Pharm Res. 2020. PMID: 32922478 Free PMC article.
-
Controlling subcellular delivery to optimize therapeutic effect.Ther Deliv. 2010 Jul;1(1):169-93. doi: 10.4155/tde.10.8. Ther Deliv. 2010. PMID: 21113240 Free PMC article. Review.
-
Effect of superparamagnetic iron oxide nanoparticles on fluidity and phase transition of phosphatidylcholine liposomal membranes.Int J Nanomedicine. 2015 Sep 29;10:6089-103. doi: 10.2147/IJN.S89679. eCollection 2015. Int J Nanomedicine. 2015. PMID: 26491286 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources